Inno-Gene Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Inno-Gene's earnings have been declining at an average annual rate of -35.1%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 3.7% per year.
Anahtar bilgiler
-35.1%
Kazanç büyüme oranı
-34.5%
EPS büyüme oranı
Life Sciences Sektör Büyümesi | 26.0% |
Gelir büyüme oranı | 3.7% |
Özkaynak getirisi | -221.4% |
Net Marj | -1,668.9% |
Sonraki Kazanç Güncellemesi | 08 Nov 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Here's Why We Think Inno-Gene (WSE:IGN) Might Deserve Your Attention Today
Jul 25Here's Why We Think Inno-Gene (WSE:IGN) Is Well Worth Watching
Apr 05Here's Why I Think Inno-Gene (WSE:IGN) Is An Interesting Stock
Dec 28Should You Be Adding Inno-Gene (WSE:IGN) To Your Watchlist Today?
Aug 28We Wouldn't Rely On Inno-Gene's (WSE:IGN) Statutory Earnings As A Guide
Feb 17Gelir ve Gider Dağılımı
Inno-Gene nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 0 | -6 | 2 | 0 |
31 Mar 24 | 0 | -1 | 2 | 0 |
31 Dec 23 | 1 | -6 | 3 | 0 |
30 Sep 23 | 2 | -2 | 4 | 0 |
30 Jun 23 | 3 | -2 | 6 | 0 |
31 Mar 23 | -9 | -6 | -1 | 0 |
31 Dec 22 | 16 | 0 | 12 | 0 |
30 Sep 22 | 24 | 0 | 15 | 0 |
30 Jun 22 | 33 | 3 | 16 | 0 |
31 Mar 22 | 39 | 10 | 15 | 0 |
31 Dec 21 | 30 | 6 | 12 | 0 |
30 Sep 21 | 23 | 6 | 8 | 0 |
30 Jun 21 | 15 | 5 | 4 | 0 |
31 Mar 21 | 6 | 1 | 2 | 0 |
31 Dec 20 | 5 | 0 | 1 | 0 |
30 Sep 20 | 3 | 1 | 1 | 0 |
30 Jun 20 | 2 | 0 | 1 | 0 |
31 Mar 20 | 1 | 0 | 1 | 0 |
31 Dec 19 | 1 | 0 | 1 | 0 |
30 Sep 19 | 1 | -1 | 1 | 0 |
30 Jun 19 | 2 | 1 | 1 | 0 |
31 Mar 19 | 3 | 1 | 1 | 0 |
31 Dec 18 | 3 | 0 | 2 | 0 |
30 Sep 18 | 3 | 1 | 2 | 0 |
30 Jun 18 | 3 | 1 | 2 | 0 |
31 Mar 18 | 3 | 1 | 2 | 0 |
31 Dec 17 | 3 | 1 | 2 | 0 |
30 Sep 17 | 4 | 0 | 3 | 0 |
30 Jun 17 | 4 | -1 | 3 | 0 |
31 Mar 17 | 4 | -2 | 3 | 0 |
31 Dec 16 | 5 | -3 | 4 | 0 |
30 Sep 16 | 5 | -3 | 5 | 0 |
30 Jun 16 | 4 | -3 | 4 | 0 |
31 Mar 16 | 5 | -1 | 4 | 0 |
31 Dec 15 | 4 | -1 | 4 | 0 |
30 Sep 15 | 4 | 1 | 3 | 0 |
30 Jun 15 | 4 | 2 | 3 | 0 |
31 Mar 15 | 4 | 2 | 2 | 0 |
31 Dec 14 | 4 | 2 | 2 | 0 |
30 Sep 14 | 4 | 0 | 2 | 0 |
30 Jun 14 | 4 | -1 | 2 | 0 |
31 Mar 14 | 3 | -1 | 2 | 0 |
31 Dec 13 | 3 | 0 | 2 | 0 |
Kaliteli Kazançlar: IGN is currently unprofitable.
Büyüyen Kar Marjı: IGN is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: IGN is unprofitable, and losses have increased over the past 5 years at a rate of 35.1% per year.
Büyüme Hızlandırma: Unable to compare IGN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: IGN is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-0.7%).
Özkaynak Getirisi
Yüksek ROE: IGN has a negative Return on Equity (-221.37%), as it is currently unprofitable.